Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter study

Yekedüz, EmreÖzbay, Mehmet FatihÇağlayan, DilekYıldırım, AtilaErol, CihanYıldırım, Hasan ÇağrıTunç, SezaiÖzyurt, NeslihanÖzdemir, FeyyazŞendur, Mehmet Ali NahitKılıçkap, Saadettin2022-04-252022-04-2520220732-183Xhttps://doi.org/10.1200/JCO.2022.40.4_suppl.130https://hdl.handle.net/20.500.12713/2655Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter studyeninfo:eu-repo/semantics/closedAccessClinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter studyOther404WOS:000770995900126Q110.1200/JCO.2022.40.4_suppl.130